UnitedHealth Group Incorporated (NYSE:UNH) is Lindenwold Advisors INC’s 8th Largest Position

Lindenwold Advisors INC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,907 shares of the healthcare conglomerate’s stock after purchasing an additional 37 shares during the period. UnitedHealth Group comprises about 2.6% of Lindenwold Advisors INC’s portfolio, making the stock its 8th biggest position. Lindenwold Advisors INC’s holdings in UnitedHealth Group were worth $5,208,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group during the 3rd quarter worth $27,000. Macroview Investment Management LLC grew its holdings in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the period. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the second quarter worth about $31,000. Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC increased its holdings in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent research reports. Cantor Fitzgerald upped their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Barclays reduced their price target on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Finally, UBS Group cut their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $589.65 on Tuesday. The firm has a market capitalization of $542.64 billion, a PE ratio of 38.41, a P/E/G ratio of 1.74 and a beta of 0.58. The business’s fifty day moving average price is $582.75 and its two-hundred day moving average price is $550.66. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same period last year, the firm earned $6.56 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.